Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]

    R. Ruiter, L. E. Visser, B. H. Ch. Stricker in Diabetologia (2012)

  2. Article

    Open Access

    Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study

    Several publications suggest an association between certain types of insulin and cancer, but with conflicting results. We investigated whether insulin glargine (A21Gly,B31Arg,B32Arg human insulin) is associate...

    R. Ruiter, L. E. Visser, M. P. P. van Herk-Sukel, J. W. W. Coebergh in Diabetologia (2012)

  3. No Access

    Article

    Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study

    The objective of this study was to investigate whether common variation in genes involved in lipid metabolism modify the effect of statins on serum total cholesterol concentration. Statin users were identified...

    C E de Keyser, M Eijgelsheim, A Hofman, E J G Sijbrands in The Pharmacogenomics Journal (2011)

  4. Article

    Open Access

    Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies

    In pharmaco-epidemiology, the use of drugs is the determinant of interest when studying exposure-outcome associations. The increased availability of computerized information about drug use on an individual bas...

    B. H. Ch. Stricker, T. Stijnen in European Journal of Epidemiology (2010)

  5. No Access

    Article

    Interaction between polymorphisms in the renin–angiotensin–system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke

    This study investigates whether the interaction between angiotensin-converting enzyme (ACE) inhibitors or β-blockers and the ACE insertion/deletion (I/D) polymorphism or angiotensin receptor II type 1 (AGTR1) ...

    H Schelleman, O H Klungel, J C M Witteman, M M B Breteler in The Pharmacogenomics Journal (2008)

  6. Article

    Genetic variation in the NOS1AP gene is associated with the incidence of diabetes mellitus in users of calcium channel blockers

    M. L. Becker, L. E. Visser, C. Newton-Cheh, J. C. M. Witteman, A. Hofman in Diabetologia (2008)

  7. Article

    Open Access

    Estrogen receptor α polymorphisms and postmenopausal breast cancer risk

    The estrogen receptor alpha (ESR1) is a mediator of estrogen response in the breast. The most studied variants in this gene are the PvuII and XbaI polymorphisms, which have been associated to lower sensitivity to...

    A. M. González-Zuloeta Ladd, A. Arias Vásquez in Breast Cancer Research and Treatment (2008)

  8. No Access

    Article

    Diuretic–gene interaction and the risk of myocardial infarction and stroke

    This study investigates whether the interaction between diuretics and alpha-adducin (ADD1) G460W or G-protein β3-subunit (GNB3) rs2301339 polymorphism modifies the risk of myocardial infarction (MI) or stroke. Da...

    H Schelleman, O H Klungel, J C M Witteman, M M B Breteler in The Pharmacogenomics Journal (2007)

  9. No Access

    Article

    Differential Roles of Angiotensinogen and Angiotensin Receptor type 1 Polymorphisms in Breast Cancer Risk

    While angiotensinogen (AGT) seems to have anti proliferative properties, angiotensin II (ATII) is a potent growth factor and it mediates its actions through the angiotensin type 1 receptor (AGTR1). In the AGT ...

    A. M. González-Zuloeta Ladd, A. Arias Vásquez in Breast Cancer Research and Treatment (2007)

  10. No Access

    Article

    Interleukin 6 G−174 C polymorphism and breast cancer risk

    Interleukin-6 (IL-6) is a growth factor involved in many processes including carcinogenesis. The C allele of the G−174 C promoter single nucleotide polymorphism (SNP) in the IL-6 gene decreases levels of IL-6 ...

    A. M. González-Zuloeta Ladd, A. Arias Vásquez in European Journal of Epidemiology (2006)

  11. Article

    Open Access

    The association between antihypertensive drugs and glioma

    We pursued an association between hypertension and gliomas by investigating whether antihypertensive drugs (AHD) are associated with an increased glioma risk by a population-based nested case–control study usi...

    M P W A Houben, J W W Coebergh, R M C Herings, M K Casparie in British Journal of Cancer (2006)

  12. No Access

    Article

    Interactions between five candidate genes and antihypertensive drug therapy on blood pressure

    Despite the availability of effective antihypertensive drugs, there is a large variation in response to these drugs. This study investigates whether polymorphisms in the angiotensin converting enzyme (I/D), an...

    H Schelleman, B H Ch Stricker, W M M Verschuren, A de Boer in The Pharmacogenomics Journal (2006)

  13. No Access

    Article

    Repeated nitrate prescriptions as a potential marker for angina pectoris A comparison with medical information from the Rotterdam Study

    Objective: The objective of this study was to determine whether pharmacy records of nitrate prescriptions could be used as a marker of angina pectoris.Method: This study was conducted within the Rotterdam Study,...

    A.H. Maitland‐van der Zee, O.H. Klungel, H.G.M. Leufkens in Pharmacy World and Science (2003)

  14. No Access

    Article

    Commentary: Drug safety epidemiology: Time for Europe to start using this instrument

    B.H.Ch. Stricker in European Journal of Epidemiology (2003)

  15. No Access

    Article

    Utilisation of malaria prophylaxis: the effect of changes in guidelines in the Netherlands, 1993‐1998

    Introduction: The increase in international travelling from temperate zones to tropical countries and increasing drug resistance of Plasmodium falciparum has resulted in a growing number of travellers that are a...

    M.M. van Riemsdijk, M.C.J.M. Sturkenboom, H.J. Schilthuis in Pharmacy World and Science (2003)

  16. No Access

    Article

    Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease

    Aim: The aim of this study was to determine whether use of antiparkinsonian drugs in pharmacy records can be used as a marker for patients with Parkinson's disease (PD). Method: Data were obtained from the Rotte...

    D.A.M.C. van de Vijver, A.J. Porsius, A. de Boer in Pharmacy World and Science (2001)

  17. No Access

    Article

    Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands

    Introduction: Shortly after their introduction, fluoroquinolones were associated with reports of tendinitis and tendon rupture. During the past years, the number of reports has risen, possibly because of an incr...

    P.D. van der Linden, B.H.Ch Stricker, H.G.M. Leufkens in Pharmacy World and Science (2001)

  18. No Access

    Article

    Cough due to ace inhibitors: a case-control study using automated general practice data

    Objectives: To determine the risk of coughing as an adverse reaction to ACE inhibitors under everyday circumstances in a large population, and to study whether this adverse effect was duration or dose dependent.

    L. E. Visser, B. H. Ch. Stricker, A. E. Vlug in European Journal of Clinical Pharmacology (1996)

  19. No Access

    Article

    Abstracts of papers and posters

    C. C. M. Veninga, P. Denig, F. M. Haaijer-Ruskamp in Pharmacy World and Science (1995)

  20. No Access

    Article

    Abstracts of papers and posters Meeting on Pharmaceutical Sciences

    Russell C. Coile Jr., K. Wiedhaup, Ilva van Bommel in Pharmacy World and Science (1993)

previous disabled Page of 2